Effects of astragaloside IV on myocardial fibrosis and energy metabolism in chronic heart failure rats
	    		
		   		
		   			 
		   		
	    	
    	 
    	10.3969/j.issn.1000-4718.2017.03.005
   		
        
        	
        		- VernacularTitle:黄芪甲苷对慢性心衰大鼠心肌纤维化及能量代谢的影响
- Author:
	        		
		        		
		        		
			        		Bin TANG
			        		
			        		;
		        		
		        		
		        		
			        		Jinguo ZHANG
			        		
			        		;
		        		
		        		
		        		
			        		Hongyong TAN
			        		
			        		;
		        		
		        		
		        		
			        		Xiqing WEI
			        		
			        		
		        		
		        		
		        		
 
			        		
			        		
		        		 
- Keywords:
        			
	        			
	        				
	        				
			        		
				        		Energy metabolism;
			        		
			        		
			        		
				        		Astragaloside IV;
			        		
			        		
			        		
				        		Chronic heart failure;
			        		
			        		
			        		
				        		Myocardial fibrosis
			        		
			        		
	        			
        			
        		
- From:
	            		
	            			Chinese Journal of Pathophysiology
	            		
	            		 2017;33(3):411-416
	            	
            	
- CountryChina
- Language:Chinese
- 
		        	Abstract:
			       	
			       		
				        
				        	AIM:To observe the effects of astragaloside IV (AS-IV) on myocardial fibrosis in chronic heart failure ( CHF) rats and to explore the underlying mechanism preliminarily .METHODS:Chronic heart failure model rats established by abdominal aorta constriction (AAC) were divided into CHF group, valsartan group and AS-IV group.Sham operation group was also established .The rats in valsartan group and AS-IV group received valsartan and AS-IV at 2 and 30 mg· kg-1 · d-1 , respectively.The rats in sham operation group and CHF group received normal saline .After 8 weeks of treatment, the cardiac structure and the hemodynamic parameters were measured .The morphologic changes of myocardial tissue were observed after staining .The expression of long-chain acyl-CoA dehydrogenase ( LCAD) and 6-phosphofructoki-nase-1 (PFK1) at mRNA and protein levels was determined by RT-qPCR and Western blot.RESULTS:Compared with sham operation group , left ventricular mass index ( LVMI) , collagen volume fraction ( CVF) , left ventricular posterior wall depth (LVPWD), and the mRNA and protein of PFK1 in CHF group were increased (P<0.05), while the mRNA and protein levels of LCAD were decreased (P<0.05).Compared with CHF group, the LVMI, CVF, LVPWD, and the mRNA and protein levels of PFK1 in valsartan group and AS-IV group were decreased (P<0.05), while the mRNA and protein levels of LCAD were increased (P<0.05).CONCLUSION:AS-IV inhibits myocardial fibrosis in the CHF rats , the mechanism of which might be associated with up-regulating the expression of LCAD , down-regulating the expression of PFK1 and normalizing the myocardial energy metabolism .